Stock screenerAll disclosures →
EDGAR →
PRQR
Conviction 49HealthcareScan · Mon, Aug 10, 2026PRQR$1.81-3.73%
ResistanceSupportVol 14Insider buyVol MA14 738.08K
May 11May 28Jun 16Jul 6Jul 23Aug 10
ProQR Therapeutics N.V.www.proqr.com ↗
Price1.81
Change-3.73%
Gap-1.33%
Rel volume0.37×
Avg volume824.94K
Avg $ vol1.49M
SMA 201.78
SMA 501.69
SMA 2001.82
Price vs 50+6.57%
Price vs 200-0.62%
MA stackmixed
50/200 cross—
Supertrendup · 1.58
RSI (14)52
MACD hist0.01
MACD crossbull · 3d
Stoch %K / %D43 / 59
ADX (14)12
+DI / −DI25 / 19
RSI divergence—
MACD divergence—
ATR %+6.68%
ADR %5.93%
52w high3.05
52w low1.37
From 52w high-40.82%
Above 52w low+31.75%
New 52w highNo
SqueezeOn · 15d
Bollinger width17.15%
%B0.58
Donchian pos48.68%
Donchian high2.00
Donchian low1.62
AVWAP (52w high)1.80
vs AVWAP high+0.50%
AVWAP (52w low)1.68
vs AVWAP low+7.53%
OBV trendFlat
Chaikin MF (20)-0.13
Today vs 20d0.37×
Avg vol (14d)738.08K
Avg vol (20d)824.94K
Avg $ vol (20d)1.49M
Market cap190.18M
RS 3m (vs SPY)+12.97%
RS 6m (vs SPY)+14.31%
RS line new highNo
Trend template3/8
Technical rank62.3
1 week+5.56%
1 month+4.34%
3 months+14.24%
6 months+20.33%
1 year-11.95%
YTD-9.30%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value190.18M
Revenue—
Net income—
Gross profit—
Free cash flow—
Industry—
ExchangeNasdaq
Shares out105.36M
Employees187
ListedThu, Sep 18, 2014
Free float86.81M
Float %82.4%
Short interest2.31M
Days to cover1.8d
Short volume42.9%
Squeeze score16 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction49 / 100
Pattern quality—
Tech rank62.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.99
Support1.43
Days since event—
Candle confirm—
News sentiment—
Congress activity
Disclosed STOCK Act trades in PRQR
No recent disclosed trades by Congress in PRQR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PRQR · 5 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
de Boer Daniel Anton Chief Executive Officer · Ordinary Shares · 2026-07-09 | Buy | 150K | $261K | 2026-07-09 | 2026-07-13 |
de Boer Daniel Anton Chief Executive Officer · Ordinary Shares · 2026-07-07 | Buy | 150K | $239K | 2026-07-07 | 2026-07-08 |
Filius Bart Director · Ordinary Shares · 2026-06-26 | Buy | 150K | $231K | 2026-06-26 | 2026-06-30 |
Hinsch Gylvin Lykke Director · Share Option (Right to Buy) · 2026-06-02 | Grant | 14.6K | — | 2026-06-02 | 2026-06-30 |
Hinsch Gylvin Lykke Director · Share Option (Right to Buy) · 2026-06-02 | Grant | 14.49K | $0 | 2026-06-02 | 2026-06-03 |
SEC filings
EDGAR filings in PRQR · 10 recent
- 13D/GSCHEDULE 13D/AWed, Jul 29, 2026
- 13D/GSCHEDULE 13GWed, Jul 29, 2026
- 13D/GSCHEDULE 13G/AFri, Jul 24, 2026
- OFFER424B5Wed, Jul 15, 2026
- 13D/GSCHEDULE 13G/AWed, Jul 15, 2026
- 13D/GSCHEDULE 13D/ATue, Jun 30, 2026
- 8-K6-KFri, Jun 26, 2026
- OFFER424B5Fri, Jun 26, 2026
- 8-K6-KThu, Jun 25, 2026
- 13D/GSCHEDULE 13D/AWed, Jun 3, 2026
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.